Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2024-04-21 21:22 |
![]() CAMERZAN, Iraida, GARBUZ, Victor, ODAJIU, Otilia. Efectul tehnologiei picco în supraviețuirea pacienților cu diabet zaharat decompensat pe fundalul stărilor septice în UTI. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 393. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 393-393 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Background. Patients with DM have an increased risk of rapid metabolic decompensation during septic process with altered hemodynamics, followed by changes of vascular permeability. Current guidelines recommend PiCCO monitoring of fluid and vasopressor infusion therapy. Objective of the study. The evolution of the impact of PiCCO technology on the prognosis and ICU length of stay of critical patients with decompensated DM (ketoacidosis) in the context of septic conditions. Material and Methods. A retrospective study(2017-2019ICU CMH ,,Sf. Treime”) of 60 critical patients(average age 35.68±3.45years)requiring infusion therapy,vasopressors,inotropes,correction of ABB,blood glucose,divided into 2groups.In groupI(n27)complex intensive therapy(CIC)was applied,guided by PiCCO(measurement of dynamic and volumetric parameters)and in groupII(n33)CIC guided by the measurement of static parameters. Results. According to the study data, on admission to the ICU, the patients from group I scored a higher APACHE II and SOFA (group I (APACHE 18p ± 2.45, P = 0.195; SOFA 10p ± 2,782 P = 0.25) vs group II (APACHE 16p ± 1.95, P = 0.203; SOFA 9p ± 2.75, P = 0.321)), and at the end of the treatment - a reduction of the ICU length of stay (group I (3.2 days ± 1.23, P = 0.265) vs group II (5.8 days ± 1.25. Also, a significant reduction of lethal outcomes was observed in patients from group I (9.40%, P = 0.130) vs group II (13.15%, P = 0.123). Conclusion. Fluid resuscitation guided by PiCCO technology in the intensive care complex applied to patients with septic conditions and decompensated DM (ketoacidosis) showed an improvement in the survival rate of patients in group I vs group II, with a reduction of the ICU length of stay. |
||||||
Cuvinte-cheie PICCO tehnology, ketoacidosis, septic conditions, tehnologia PICCO, cetoacidoză, stări septice |
||||||
|